Compositions of anti-viral peptides and/or compounds and methods of use thereof
AssigneeThe University of Hong Kong
InventorsHanjun Zhao, Kwok-Yung Yuen
Life of this patent
Estimating the term…
Abstract
Broad spectrum antiviral peptides and compositions including therapeutically effective amounts of the antiviral peptides along with a pharmaceutically acceptable carrier are provided. The antiviral compositions show a strong broad spectrum antiviral effect, without resulting to viral resistance. The antiviral compositions are useful for treatment of diseases caused by viral infections, particularly respiratory viruses such as enveloped coronaviruses (SARS-CoV-2, SARS-CoV and MERS-CoV), the pandemic A (H1N1) pdm09 virus, avian influenza A (H7N9) virus, and the non-enveloped rhinovirus.
Claims29
An antiviral agent comprising a multivalent peptide, wherein the multivalent peptide comprises three or more copies of one or a combination of peptides selected from the group consisting of P9R (SEQ ID NO:2) and P9R-like peptides derived from P9R,
- wherein at least three of the peptides that comprise the multivalent peptide branch from one or more of the peptides that comprise the multivalent peptide.
12-15. (canceled)
An antiviral agent comprising P9R (SEQ ID NO:2) or a P9R-like peptide derived from P9R.
20-21. (canceled)
An antiviral composition comprising arbidol, chloroquine, and camostat.
(canceled)
33-34. (canceled)
Dependencies are inferred from the claim text.